ANGIOTECH PHARMACEUTICALS INC Depreciation and Amortization Expense
ANGIOTECH PHARMACEUTICALS INC reported Depreciation and Amortization Expense of $34.50 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DepreciationAndAmortization · last filed 2013-03-28
- ANGIOTECH PHARMACEUTICALS INC depreciation, depletion and amortization, nonproduction for the quarter ending 2012-12-31 was $8.61M.
- ANGIOTECH PHARMACEUTICALS INC depreciation, depletion and amortization, nonproduction for the quarter ending 2012-09-30 was $8.45M, a 8.66% decline year-over-year.
- ANGIOTECH PHARMACEUTICALS INC depreciation, depletion and amortization, nonproduction for the quarter ending 2012-06-30 was $8.43M.
- ANGIOTECH PHARMACEUTICALS INC depreciation, depletion and amortization, nonproduction for the quarter ending 2012-03-31 was $9.02M.
- ANGIOTECH PHARMACEUTICALS INC depreciation, depletion and amortization, nonproduction for fiscal 2012 was $34.50M.
| Period end | Depreciation, Depletion and Amortization, Nonproduction 2 month | Depreciation, Depletion and Amortization, Nonproduction 3 month | Depreciation, Depletion and Amortization, Nonproduction 5 month | Depreciation, Depletion and Amortization, Nonproduction 6 month | Depreciation, Depletion and Amortization, Nonproduction 8 month | Depreciation, Depletion and Amortization, Nonproduction 9 month | Depreciation, Depletion and Amortization, Nonproduction 12 month |
|---|---|---|---|---|---|---|---|
| 2012-12-31 | $8.61M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $17.05M derived: sum of 2 quarters · filed 2013-03-28 | $25.48M derived: sum of 3 quarters · filed 2013-03-28 | $34.50M 10-K · filed 2013-03-28 | |||
| 2012-09-30 | $8.45M 10-Q · filed 2012-11-14 | $16.87M derived: sum of 2 quarters · filed 2012-11-14 | $25.90M 10-Q · filed 2012-11-14 | ||||
| 2012-06-30 | $8.43M 10-Q/A · filed 2012-09-13 | $17.45M 10-Q/A · filed 2012-09-13 | |||||
| 2012-03-31 | $9.02M 10-Q · filed 2012-05-15 | ||||||
| 2011-12-31 | $23.97M 10-K · filed 2013-03-28 | ||||||
| 2011-09-30 | $9.25M 10-Q · filed 2012-11-14 | $14.94M 10-Q · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | ||||
| 2011-06-30 | $5.69M 10-Q/A · filed 2012-09-13 |